Shares of Merck KGaA (ETR:MRK – Get Free Report) fell 1.8% during mid-day trading on Tuesday . The company traded as low as €125.90 and last traded at €125.90. 186,294 shares were traded during trading, The stock had previously closed at €128.15.
Merck KGaA Price Performance
The business has a fifty day moving average price of €124.97 and a 200 day moving average price of €117.12. The company has a market capitalization of $56.07 billion, a price-to-earnings ratio of 20.68, a price-to-earnings-growth ratio of 2.37 and a beta of 0.71.
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies.
Read More
- Five stocks we like better than Merck KGaA
- Unlocked: Elon Musk’s Next Big IPO
- This makes me furious
- The “Trump Effect” on IRAs over $50k
- Silver paying 20% dividend. Plus 68% share gains
- America’s 1776 happening again
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
